DexCom (NASDAQ:DXCM) managed to eke out gains of 0.12% in intraday trade. The share price increased by 0.1 points to $77.34. Till last observation, the net money flow was recorded at a negative $(-0.94) million. The total inflow of $1.92 million in upticks was completely overshadowed by an outflow of $2.85 million in downticks, giving the up/down ratio a value of 0.67. The shares have seen a change of 6.52% in the past week.A block trade occurred in the company shares in which the composite value of the upticks was $0 million and the composite value in downticks was $1.4 million. The resultant up/down ratio for the block exchange was 0. The block trade had a negative money flow of $(-1.4) million.
The stock has recorded a 20-day Moving Average of 12.1% and the 50-Day Moving Average is 16.55%. The company shares have dropped 0.89% in the past 52 Weeks. On September 17, 2015 The shares registered one year high of $103.29 and one year low was seen on February 8, 2016 at $47.92. The 50-day moving average is $66.23 and the 200 day moving average is recorded at $69.04. S&P 500 has rallied 1.93% during the last 52-weeks.
DexCom (NASDAQ:DXCM): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $77.74 and $75.55 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $77.74. The buying momentum continued till the end and the stock did not give up its gains. It closed at $77.51, notching a gain of 0.35% for the day. The total traded volume was 1,152,381 . The stock had closed at $77.24 on the previous day.
Currently the company Insiders own 2.8% of DexCom shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -7.3% . Institutional Investors own 94.23% of DexCom shares. During last six month period, the net percent change held by insiders has seen a change of -7.42%. On the companys insider trading activities, The Securities and Exchange Commission has divulged that Moy Jeffrey, officer (SVP, Operations) of Dexcom Inc, had unloaded 6,910 shares at an average price of $74 in a transaction dated on June 9, 2016. The total value of the transaction was worth $511,340.
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.